Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurea Biolabs is an innovative nutraceutical company focused on the development of high-efficacy natural ingredients through advanced bioprocessing technologies. A subsidiary of Plant Lipids, the company is best known for its proprietary Polar-Non-polar Sandwich (PNS) technology, which significantly improves the bioavailability of phytonutrients like curcumin. Their commercial portfolio includes clinically validated brands such as Cureit, AcuJoint, and Fit-N-Lean, which address global health concerns in inflammation, joint care, and metabolic wellness. Headquartered in India, Aurea Biolabs operates state-of-the-art R&D and manufacturing facilities that comply with international quality standards including GMP and ISO. The company serves as a key partner for global dietary supplement brands seeking science-backed, plant-derived functional components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurea Biolabs.